Filing Flows › Sanuwave Health (SNWV) › Q1 2026 › vs Q4 2025
Sanuwave Health (SNWV) Q1 2026 vs Q4 2025 (quarter over quarter)
Sanuwave Health's revenue fell $3.8M (-28%) from $13.4M in Q4 2025 to $9.6M in Q1 2026.
Sanuwave Health, Q1 2026: revenue $9.6M (+3% year over year), operating margin -11.7%, net loss $1.4M, operating cash flow $397K. The chart draws each line against Q4 2025, the increases inside each band.
Margins
| Q1 2026 | Q4 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 3.9% | 24.1% | -20.2 pts |
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $9.6M | $13.4M | −$3.8M | -28% |
| Net loss | $1.4M | −$7.7M | $9.1M | — |
| Costs & expenses | $11.1M | $19.1M | −$8.0M | -42% |
| Operating costs | $10.7M | $11.4M | −$648K | -6% |
| Interest & other, net | $315K | −$5.7M | $6.0M | — |
| Cost of revenue | $2.2M | $3.4M | −$1.2M | -35% |
| Research & development | $660K | $606K | $54K | +9% |
| Sales & marketing | $2.4M | $2.1M | $266K | +12% |
| General & admin | $5.2M | $5.0M | $282K | +6% |
| Other operating costs | $246K | $292K | −$46K | -16% |
| Operating cash sources | $1.9M | $1.7M | $228K | +14% |
| Depreciation & amortization | $294K | $340K | −$46K | -14% |
| Share-based compensation | $1.6M | $1.3M | $274K | +20% |
| Net loss absorbed | $1.4M | −$7.7M | $9.1M | — |
| Working capital & other | $69K | $6.0M | −$6.0M | -99% |
| Operating cash flow | $397K | $3.3M | −$2.9M | -88% |
| Free cash flow (OCF − capex) | $374K | $3.2M | −$2.8M | -88% |
| Capital expenditures | $23K | $96K | −$73K | -76% |
Questions
How much did Sanuwave Health's revenue grow quarter over quarter in Q1 2026?
Sanuwave Health's revenue fell $3.8M (-28%) from $13.4M in Q4 2025 to $9.6M in Q1 2026.